{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:51:05Z","timestamp":1773273065023,"version":"3.50.1"},"reference-count":10,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dupilumab, a biologic drug approved for the treatment of moderate\u2010to\u2010severe atopic dermatitis, has been associated with resolution or improvement in pre\u2010existing alopecia areata. We report a case of significant improvement of AA after Dupilumab\u2010onset treatment for atopic dermatitis and review the literature.<\/jats:p>","DOI":"10.1111\/ajd.13208","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:25:11Z","timestamp":1574727911000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature"],"prefix":"10.1111","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0046-6962","authenticated-orcid":false,"given":"Jorge","family":"Magdaleno\u2010Tapial","sequence":"first","affiliation":[{"name":"Department of Dermatology Hospital General Universitario de Valencia Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4435-4172","authenticated-orcid":false,"given":"Cristian","family":"Valenzuela\u2010O\u00f1ate","sequence":"additional","affiliation":[{"name":"Department of Dermatology Hospital General Universitario de Valencia Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Garc\u00eda\u2010Legaz\u2010Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Dermatology Hospital General Universitario de Valencia Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1252-1001","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Mart\u00ednez\u2010Domenech","sequence":"additional","affiliation":[{"name":"Department of Dermatology Hospital General Universitario de Valencia Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"P\u00e9rez\u2010Ferriols","sequence":"additional","affiliation":[{"name":"Department of Dermatology Hospital General Universitario de Valencia Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.10.010"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16711"},{"key":"e_1_2_4_4_1","first-page":"1","article-title":"Dupilumab and alopecia: causative or therapeutic?","author":"Hendricks AJ","year":"2019","journal-title":"Dermatol. Basel Switz."},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.11.006"},{"key":"e_1_2_4_6_1","first-page":"602","article-title":"[Dupilumab\u2010associated healing of alopecia areata in an atopic dermatitis patient]","volume":"144","author":"Aszodi N","year":"2019","journal-title":"Dtsch Med. Wochenschr 1946"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2976"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.11.007"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13778"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3183"},{"key":"e_1_2_4_11_1","unstructured":"Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD). ClinicalTrials.gov Identifier: NCT03359356 (https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03359356)."}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.13208","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajd.13208","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.13208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T10:04:26Z","timestamp":1733738666000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.13208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1111\/ajd.13208"],"URL":"https:\/\/doi.org\/10.1111\/ajd.13208","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"2019-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}